D59.12
Cold autoimmune hemolytic anemia
Clinical Classification Guidelines
Inclusion Terms
- Chronic cold hemagglutinin disease
- Cold agglutinin disease
- Cold agglutinin hemoglobinuria
- Cold type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia
- Cold type autoimmune hemolytic disease
Medical Intelligence & Overview
Cold autoimmune hemolytic anemia, also known as cold agglutinin disease, is a rare condition where the immune system mistakenly attacks and destroys red blood cells at cooler temperatures. This process can lead to anemia, a condition characterized by a shortage of healthy red blood cells, which are essential for transporting oxygen throughout the body. The disorder can be primary (occurring on its own) or secondary (linked to other diseases or infections). It’s important to understand this condition to recognize its effects and seek appropriate medical attention.
Causes & Symptoms
Clinical Causes: Primary cold autoimmune hemolytic anemia, which occurs without an underlying disease. Secondary cases linked to other health issues such as certain infections (e.g., Mycoplasma pneumoniae, Epstein-Barr virus), or other illnesses like lymphomas and other blood cancers. Cold exposure or working in cold environments can exacerbate symptoms due to temperature sensitivity. Some cases are associated with autoimmune disorders where the immune system mistakenly targets its own cells. In certain instances, drugs or medications can trigger this condition.
Key Symptoms: Fatigue and weakness due to decreased red blood cells. Paleness or pallor, especially in the skin and mucous membranes. Cyanosis, which is a bluish discoloration of the lips or fingers when exposed to cold. Skin rashes or color changes, often worsened by cold exposure. Chills, shivering, or feeling cold more intensely than usual. Dark urine caused by hemoglobinuria, which results from the destruction of red blood cells releasing hemoglobin into the urine. Shortness of breath or dizziness in severe cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests that identify hemolytic anemia and the presence of cold agglutinins, which are antibodies that activate at lower temperatures. Specific tests include the direct antiglobulin test (Coombs test), cold agglutinin titers, and examining blood smears under a microscope. Doctors may also evaluate underlying conditions or infections that could be contributing to the disease. It’s recommended to observe symptoms during cold exposure to assess their correlation.
Treatment Protocols: Managing cold autoimmune hemolytic anemia involves strategies to reduce the activity of cold agglutinins and prevent hemolysis. Common approaches include: - Avoiding cold environments and exposure to cold temperatures. - Using warm clothing and maintaining a warm indoor environment. - Medications such as corticosteroids may be prescribed to suppress immune activity. - Rituximab, a monoclonal antibody, can be used in some cases to target specific immune cells. - Treating any underlying infections or associated conditions that might be causing secondary cases. - In severe cases, blood transfusions or plasmapheresis may be considered to manage symptoms. It is essential to work closely with healthcare professionals to develop an individualized management plan.
Clinical Advice & FAQs
Billing Guidance
Is D59.12 a billable ICD-10 code?
Yes, D59.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D59.12?
Clinical documentation must specify the nature of Cold autoimmune hemolytic anemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference